Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Hyperbaric oxygen therapy for severe ulcerative colitis.

A L Buchman1, C Fife, C Torres

  • 1Division of Gastroenterology and Hepatology, Northwestern University Medical School, Chicago, Illinois 60611, USA. a-buchman@nwu.edu

Journal of Clinical Gastroenterology
|October 6, 2001
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Enhancement of wheat seed germination using double dielectric barrier discharges with electrodes immersed in a conductive liquid.

Scientific reports·2025
Same author

Search for Nuclear Modifications of B^{+} Meson Production in p-Pb Collisions at sqrt[s_{NN}]=8.16  TeV.

Physical review letters·2025
Same author

Cost-effectiveness of benralizumab versus mepolizumab and dupilumab in patients with severe uncontrolled eosinophilic asthma in Spain.

The Journal of asthma : official journal of the Association for the Care of Asthma·2022
Same author

Raspberry Pi based photovoltaic I-V curve tracer.

HardwareX·2022
Same author

[Impact of pharmaceutical care in polymedicated patients admitted to a geriatric ward].

Anales del sistema sanitario de Navarra·2022
Same author

Linezolid-resistant MRSA-CC398 carrying the cfr gene, and MRSA-CC9 isolates from pigs with signs of infection in Spain.

Journal of applied microbiology·2021
Same journal

GLP-1 Receptor Agonists and Hepatic Encephalopathy in Cirrhosis: A Protective Signal Requiring Cancer and Nutritional Phenotyping.

Journal of clinical gastroenterology·2026
Same journal

Endoscopic Incisional Therapy for Benign Esophageal Strictures: A Systematic Review and Meta-Analysis.

Journal of clinical gastroenterology·2026
Same journal

International Consensus Statements on the Use of Topical Endoscopic Hemostatic Powders in the Treatment of Acute Gastrointestinal Bleeding.

Journal of clinical gastroenterology·2026
Same journal

Do Risk Factors for Reflux Symptoms After Peroral Endoscopic Myotomy Necessarily Increase the Occurrence of Postoperative Gastroesophageal Reflux?

Journal of clinical gastroenterology·2026
Same journal

Subgroup Stratification by Regimen, Geography, and Population Is Necessary to Validate Nitazoxanide-based Helicobacter pylori Eradication Therapy.

Journal of clinical gastroenterology·2026
Same journal

The Impact of Glucagon-Like Peptide 1 Receptor Agonists Versus Diabetes Mellitus on Endoscopic Procedures: A Case-Control Study From a Large Tertiary Care Health System.

Journal of clinical gastroenterology·2026
See all related articles

Hyperbaric oxygen therapy offers a new treatment for ulcerative colitis. This approach successfully induced clinical remission in patients resistant to standard therapies, allowing for corticosteroid withdrawal.

Area of Science:

  • Gastroenterology
  • Hyperbaric Medicine

Background:

  • Ulcerative colitis is a chronic inflammatory bowel disease.
  • Refractory cases often require advanced treatment strategies.

Observation:

  • Hyperbaric oxygen therapy (HBOT) has previously shown success in perineal Crohn's disease.
  • This study explores HBOT for ulcerative colitis refractory to conventional treatments.

Findings:

  • Thirty HBOT sessions (100% oxygen at 2.0 atm absolute) were administered.
  • Clinical remission was achieved, confirmed by Truelove-Witts and disease activity index scores.
  • Successful tapering of corticosteroid medication was possible post-remission.

Implications:

  • HBOT presents a potential therapeutic option for severe, treatment-resistant ulcerative colitis.

Related Experiment Videos

  • Further research into HBOT mechanisms and long-term outcomes in ulcerative colitis is warranted.